thymidine 5'-triphosphate has been researched along with Cancer of Rectum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brabender, J; Hoelscher, AH; Hoffmann, AC; Ling, F; Lurje, G; Metzger, R; Schneider, PM; Vallböhmer, D; Warnecke-Eberz, U | 1 |
Fischer, PH; Pangallo, CA; Van Mouwerik, TJ; Willson, JK | 1 |
2 other study(ies) available for thymidine 5'-triphosphate and Cancer of Rectum
Article | Year |
---|---|
Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers, Tumor; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Feasibility Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Pilot Projects; Postoperative Period; Radiotherapy, Adjuvant; Rectal Neoplasms; Regression Analysis; RNA, Messenger; ROC Curve; Sensitivity and Specificity; Survival Rate; Thymine Nucleotides | 2009 |
Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
Topics: Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Drug Synergism; Guanine; Humans; Hypoxanthine; Hypoxanthines; Methotrexate; Rectal Neoplasms; Thymidine; Thymine Nucleotides | 1987 |